Pharmaceutical stocks in India showed mixed performance on March 5, 2026, during early trading hours, with many recording modest gains amid broader market movements. The S&P BSE HEALTHCARE Index stood at 43,441.0, up 0.8% at the time of the update.
The benchmark S&P BSE SENSEX was at 79,434.73, up 0.4%.
Key Sector Performance
- The S&P BSE HEALTHCARE Index gained 0.8% on the day.
- Over the last 30 days, the index rose 5.7%.
- Over the last 1 year, it increased 13.3%.
Stock Prices and Changes (as of March 5, 2026, early morning)
Prices reflect BSE and NSE quotes around 9:21 AM to 9:24 AM IST, with percentage changes:
- Aarti Drugs: BSE ₹364.00 (+1.22%), NSE ₹359.25 (-0.33%)
- Abbott India: BSE ₹28,160.00 (+1.23%), NSE ₹28,150.00 (+1.17%)
- Acutaas Chemicals: BSE ₹2,166.15 (+2.95%), NSE ₹2,197.90 (+4.44%)
- Ajanta Pharma: BSE ₹2,933.85 (+0.60%), NSE ₹2,939.50 (+0.80%)
- Alembic: BSE ₹88.00 (+1.86%), NSE ₹88.00 (+1.97%)
- Aurobindo Pharma: BSE ₹1,207.50 (+1.04%), NSE ₹1,208.10 (+1.06%)
- Biocon: BSE ₹383.40 (+1.36%), NSE ₹385.00 (+1.76%)
- Cipla: BSE ₹1,317.90 (+0.40%), NSE ₹1,322.10 (+0.68%)
- Divis Laboratories: BSE ₹6,356.00 (+0.89%), NSE ₹6,365.50 (+0.78%)
- Dr. Reddy’s Lab: BSE ₹1,301.50 (+0.80%), NSE ₹1,306.60 (+1.19%)
- Glenmark Pharma: BSE ₹2,078.60 (+1.89%), NSE ₹2,078.00 (+1.88%)
- Granules India: BSE ₹568.45 (+2.70%), NSE ₹569.55 (+2.74%)
- Laurus Labs: BSE ₹1,049.00 (+1.82%), NSE ₹1,050.00 (+1.88%)
- Lupin: BSE ₹2,341.30 (+1.60%), NSE ₹2,350.40 (+1.97%)
- Natco Pharma: BSE ₹982.85 (+3.15%), NSE ₹985.05 (+3.35%)
- Sun Pharma: BSE ₹1,765.05 (+0.90%), NSE ₹1,774.50 (+1.37%)
- Zydus Lifesciences: BSE ₹904.60 (+0.90%), NSE ₹904.20 (+0.81%)
Many other pharma stocks, including Alkem Laboratories, Eris Lifesciences, and Jubilant Pharmova, showed gains between 0.5% and 1.5%.
Some stocks traded flat or lower, such as Astrazeneca Pharma (BSE -1.12%), Indoco Remedies (BSE -1.74%), and Max Healthcare Institute (BSE -1.12%).
Top Gainers in the Sector
Within pharmaceuticals, notable gainers included:
- Source Natural Foods (up 13.3%)
- Choksi Lab (up 11.2%)
Top losers included Parmax Pharma (down 11.0%) and Fervent Synergies (down 6.2%).
Market Context
Early trading data indicates positive momentum in several large-cap and mid-cap pharma names, though overall sector movement aligned closely with the broader market’s modest uptick. Note that intraday prices can fluctuate, and this reflects snapshot data from the morning session on March 5, 2026.
For real-time updates, refer to official BSE or NSE platforms. This summary is based on provided market data and does not constitute investment advice.